Рабдомиолиза (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Рабдомиолиза" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
1st place
1st place
low place
low place
719th place
468th place
low place
6,269th place
archive.org (Global: 6th place; Serbian: 5th place)
- Sauret, J.; Marinides, G.; Wang, G. (2002). „Rhabdomyolysis”. Am Fam Physician. 65 (5): 907—912. PMID 11898964.
- Bessman, S, Carpenter, C (1985). „The creatine-creatine phosphate energy shuttle”. Annu Rev Biochem. 54: 831—862. PMID 3896131. doi:10.1146/annurev.bi.54.070185.004151..
- Hoogwerf B, Kern J, Bullock M, Comty C (1979). „Phencyclidine-induced rhabdomyolysis and acute renal failure”. Clin Toxicol. 14 (1): 47—53. PMID 436384. doi:10.3109/15563657909030113..
- Zager, R. A. (1996). „Rhabdomyolysis and myohemoglobinuric acute renal failure”. Kidney International. 49 (2): 314—326. PMID 8821813. doi:10.1038/ki.1996.48.
- Better, O. S.; Rubinstein, I; Winaver, J. M.; Knochel, J. P. (1997). „Mannitol therapy revisited (1940-1997)”. Kidney International. 52 (4): 886—94. PMID 9328926. doi:10.1038/ki.1997.409.
- Zager, R. A. (1992). „Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and Therapeutic Implications.”. J Clin Invest. 90 (3): 711—9. PMC 329921
. PMID 1325995. doi:10.1172/JCI115942.
doi.org (Global: 2nd place; Serbian: 4th place)
- Bywaters, E. G.; Beall, D. (1941). „Crush Injuries with Impairment of Renal Function”. BMJ. 1 (4185): 427—432. PMC 2161734 . PMID 20783577. doi:10.1136/bmj.1.4185.427.
- Nichols, G. A.; Koro, C. E. (2007). „Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients”. Clin Ther. 29 (8): 1761—70. PMID 17919557. doi:10.1016/j.clinthera.2007.08.022.
- Vanholder, R.; Sever, M. S.; Erek, E.; Lameire, N. (2000). „Rhabdomyolysis”. Journal of the American Society of Nephrology. 11 (8): 1553—61. PMID 10906171. doi:10.1681/ASN.V1181553.
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care. 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 .
- Mohaupt, M. G. (2003). „Rhabdomyolysis”. Ther Umsch. 60 (7): 391—397. PMID 12956032. doi:10.1024/0040-5930.60.7.391.
- Ward, M. M. (1988). „Factors predictive of acute renal failure in rhabdomyolysis”. Archives of Internal Medicine. 148 (7): 1553—1557. PMID 3382301. doi:10.1001/archinte.1988.00380070059015.
- Knochel, J. P. (1993). „Mechanisms of rhabdomyolysis”. Current Opinion in Rheumatology. 5 (6): 725—31. PMID 8117534. doi:10.1097/00002281-199305060-00006.
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care (London, England). 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 . Архивирано из оригинала 11. 02. 2021. г., Приступљено 09/2009.
- Clozel M, Anand R, Cooper C, Morrow J (1978). „Resolution of muscle calcification in rhabdomyolysis and acute renal failure”. Annals of Internal Medicine. 89 (6): 928—930. PMID 717989. doi:10.7326/0003-4819-89-6-928..
- Bohlmeyer, TJ, Wu, AHB, Perryman, MB (1994). „Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis”. Rheum Dis Clin North Am. 20 (4): 845—856. PMID 7855325. doi:10.1016/S0889-857X(21)00069-7..
- Bessman, S, Carpenter, C (1985). „The creatine-creatine phosphate energy shuttle”. Annu Rev Biochem. 54: 831—862. PMID 3896131. doi:10.1146/annurev.bi.54.070185.004151..
- Koppel, C. (1989). „Clinical features, pathogenesis and management of drug-induced rhabdomyolysis”. Med Toxicol Adverse Drug Exp. 4 (2): 108—126. PMID 2654542. doi:10.1007/BF03259907.
- Gabow, P.; Kaehny, W.; Kelleher, S. (1982). „The spectrum of rhabdomyolysis”. Medicine. 62 (3): 141—152. PMID 7078398. doi:10.1097/00005792-198205000-00002.
- Hoogwerf B, Kern J, Bullock M, Comty C (1979). „Phencyclidine-induced rhabdomyolysis and acute renal failure”. Clin Toxicol. 14 (1): 47—53. PMID 436384. doi:10.3109/15563657909030113..
- Akmal, M.; Massry, S. G. (1990). „Reversible hepatic dysfunction associated with rhabdomyolysis”. American Journal of Nephrology. 10 (1): 49—52. PMID 2343880. doi:10.1159/000168053.
- Odeh, M.; Odeh, Majed (1991). „The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.”. New England Journal of Medicine. 324 (20): 1417—22. PMID 2020298. doi:10.1056/NEJM199105163242007.
- Sinert, R.; Kohl, L.; Rainone, T.; Scalea, T. (1994). „Exercise-induced rhabdomyolysis”. Annals of Emergency Medicine. 23 (6): 1301—1306. PMID 8198305. doi:10.1016/s0196-0644(94)70356-6.
- Akmal, Mohammad; Bishop, June E.; Telfer, Nancy; Norman, Anthony W.; Massry, Shaul G. (1986). „Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure”. Journal of Clinical Endocrinology & Metabolism. 63 (1): 137—42. PMID 3011837. doi:10.1210/jcem-63-1-137.
- Zager, R. A. (1996). „Rhabdomyolysis and myohemoglobinuric acute renal failure”. Kidney International. 49 (2): 314—326. PMID 8821813. doi:10.1038/ki.1996.48.
- Better, O. S.; Rubinstein, I; Winaver, J. M.; Knochel, J. P. (1997). „Mannitol therapy revisited (1940-1997)”. Kidney International. 52 (4): 886—94. PMID 9328926. doi:10.1038/ki.1997.409.
- Homsi E, Barreiro MF, Orlando JM, Higa EM (1997). „Prophylaxis of acute renal failure in patients with rhabdomyolysis.”. Ren Fail. 19 (2): 283—8. PMID 9101605. doi:10.3109/08860229709026290..
- Zager, R. A. (1992). „Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and Therapeutic Implications.”. J Clin Invest. 90 (3): 711—9. PMC 329921 . PMID 1325995. doi:10.1172/JCI115942.
- Moore, Kevin P.; Holt, Steve G.; Patel, Rakesh P.; Svistunenko, Dimitri A.; Zackert, William; Goodier, David; Reeder, Brandon. J.; Clozel, Martine; Anand, Radhi; Cooper, Christopher E.; Morrow, Jason D.; Wilson, Michael T.; Darley-Usmar, Victor; Roberts, L. Jackson (1998). „A Causative Role for Redox Cycling of Myoglobin and Its Inhibition by Alkalinization in the Pathogenesis and Treatment of Rhabdomyolysis-induced Renal Failure”. Journal of Biological Chemistry. 273 (48): 31731—31737. PMID 9822635. doi:10.1074/jbc.273.48.31731 .
- Hollander, A. S.; Olney, R. C.; Blackett, P. R.; et al. (2003). „Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males.”. Pediatrics. 111 (1): 1447—1452. PMID 12777570. doi:10.1542/peds.111.6.1447.
medscape.com (Global: 719th place; Serbian: 468th place)
emedicine.medscape.com
- (језик: енглески) Rhabdomyolysis: Differential Diagnoses Medscape Посећено април 2010.
mif-ua.com (Global: low place; Serbian: low place)
urgent.mif-ua.com
- (језик: руски)„Л. Л. МИРОНОВ, БелМАПО, Рабдомиолиз г. Минск, Республика Беларусь”. Приступљено 28. 4. 2010.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Bywaters, E. G.; Beall, D. (1941). „Crush Injuries with Impairment of Renal Function”. BMJ. 1 (4185): 427—432. PMC 2161734 . PMID 20783577. doi:10.1136/bmj.1.4185.427.
- Nichols, G. A.; Koro, C. E. (2007). „Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients”. Clin Ther. 29 (8): 1761—70. PMID 17919557. doi:10.1016/j.clinthera.2007.08.022.
- Vanholder, R.; Sever, M. S.; Erek, E.; Lameire, N. (2000). „Rhabdomyolysis”. Journal of the American Society of Nephrology. 11 (8): 1553—61. PMID 10906171. doi:10.1681/ASN.V1181553.
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care. 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 .
- Mohaupt, M. G. (2003). „Rhabdomyolysis”. Ther Umsch. 60 (7): 391—397. PMID 12956032. doi:10.1024/0040-5930.60.7.391.
- Ward, M. M. (1988). „Factors predictive of acute renal failure in rhabdomyolysis”. Archives of Internal Medicine. 148 (7): 1553—1557. PMID 3382301. doi:10.1001/archinte.1988.00380070059015.
- Knochel, J. P. (1993). „Mechanisms of rhabdomyolysis”. Current Opinion in Rheumatology. 5 (6): 725—31. PMID 8117534. doi:10.1097/00002281-199305060-00006.
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care (London, England). 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 . Архивирано из оригинала 11. 02. 2021. г., Приступљено 09/2009.
- Clozel M, Anand R, Cooper C, Morrow J (1978). „Resolution of muscle calcification in rhabdomyolysis and acute renal failure”. Annals of Internal Medicine. 89 (6): 928—930. PMID 717989. doi:10.7326/0003-4819-89-6-928..
- Sauret, J.; Marinides, G.; Wang, G. (2002). „Rhabdomyolysis”. Am Fam Physician. 65 (5): 907—912. PMID 11898964.
- Dayer-Berenson L (1994). „Rhabdomyolysis a comprehensive guide”. Anna J. 21 (1): 15—18. PMID 8141632..
- Bohlmeyer, TJ, Wu, AHB, Perryman, MB (1994). „Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis”. Rheum Dis Clin North Am. 20 (4): 845—856. PMID 7855325. doi:10.1016/S0889-857X(21)00069-7..
- Bessman, S, Carpenter, C (1985). „The creatine-creatine phosphate energy shuttle”. Annu Rev Biochem. 54: 831—862. PMID 3896131. doi:10.1146/annurev.bi.54.070185.004151..
- Koppel, C. (1989). „Clinical features, pathogenesis and management of drug-induced rhabdomyolysis”. Med Toxicol Adverse Drug Exp. 4 (2): 108—126. PMID 2654542. doi:10.1007/BF03259907.
- Adams, E. C. (1980). „Differentiation of myoglobin and hemoglobin in biological fluids”. Ann Clin Lab Sci. 10 (6): 493—499. PMID 7447391.
- Gabow, P.; Kaehny, W.; Kelleher, S. (1982). „The spectrum of rhabdomyolysis”. Medicine. 62 (3): 141—152. PMID 7078398. doi:10.1097/00005792-198205000-00002.
- Hoogwerf B, Kern J, Bullock M, Comty C (1979). „Phencyclidine-induced rhabdomyolysis and acute renal failure”. Clin Toxicol. 14 (1): 47—53. PMID 436384. doi:10.3109/15563657909030113..
- Akmal, M.; Massry, S. G. (1990). „Reversible hepatic dysfunction associated with rhabdomyolysis”. American Journal of Nephrology. 10 (1): 49—52. PMID 2343880. doi:10.1159/000168053.
- Odeh, M.; Odeh, Majed (1991). „The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.”. New England Journal of Medicine. 324 (20): 1417—22. PMID 2020298. doi:10.1056/NEJM199105163242007.
- Sinert, R.; Kohl, L.; Rainone, T.; Scalea, T. (1994). „Exercise-induced rhabdomyolysis”. Annals of Emergency Medicine. 23 (6): 1301—1306. PMID 8198305. doi:10.1016/s0196-0644(94)70356-6.
- Akmal, Mohammad; Bishop, June E.; Telfer, Nancy; Norman, Anthony W.; Massry, Shaul G. (1986). „Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure”. Journal of Clinical Endocrinology & Metabolism. 63 (1): 137—42. PMID 3011837. doi:10.1210/jcem-63-1-137.
- Zager, R. A. (1996). „Rhabdomyolysis and myohemoglobinuric acute renal failure”. Kidney International. 49 (2): 314—326. PMID 8821813. doi:10.1038/ki.1996.48.
- Better, O. S.; Rubinstein, I; Winaver, J. M.; Knochel, J. P. (1997). „Mannitol therapy revisited (1940-1997)”. Kidney International. 52 (4): 886—94. PMID 9328926. doi:10.1038/ki.1997.409.
- Homsi E, Barreiro MF, Orlando JM, Higa EM (1997). „Prophylaxis of acute renal failure in patients with rhabdomyolysis.”. Ren Fail. 19 (2): 283—8. PMID 9101605. doi:10.3109/08860229709026290..
- Zager, R. A. (1992). „Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and Therapeutic Implications.”. J Clin Invest. 90 (3): 711—9. PMC 329921 . PMID 1325995. doi:10.1172/JCI115942.
- Moore, Kevin P.; Holt, Steve G.; Patel, Rakesh P.; Svistunenko, Dimitri A.; Zackert, William; Goodier, David; Reeder, Brandon. J.; Clozel, Martine; Anand, Radhi; Cooper, Christopher E.; Morrow, Jason D.; Wilson, Michael T.; Darley-Usmar, Victor; Roberts, L. Jackson (1998). „A Causative Role for Redox Cycling of Myoglobin and Its Inhibition by Alkalinization in the Pathogenesis and Treatment of Rhabdomyolysis-induced Renal Failure”. Journal of Biological Chemistry. 273 (48): 31731—31737. PMID 9822635. doi:10.1074/jbc.273.48.31731 .
- Hollander, A. S.; Olney, R. C.; Blackett, P. R.; et al. (2003). „Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males.”. Pediatrics. 111 (1): 1447—1452. PMID 12777570. doi:10.1542/peds.111.6.1447.
pubmedcentral.nih.gov
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care (London, England). 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 . Архивирано из оригинала 11. 02. 2021. г., Приступљено 09/2009.
web.archive.org (Global: 1st place; Serbian: 1st place)
- Huerta-Alardín, A. L.; Varon, J.; Marik, P. E. (2004). „Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians”. Critical Care (London, England). 9 (2): 158—169. PMC 1175909 . PMID 15774072. doi:10.1186/cc2978 . Архивирано из оригинала 11. 02. 2021. г., Приступљено 09/2009.
wrongdiagnosis.com (Global: low place; Serbian: 6,269th place)
- (језик: енглески)„Thomas L. Kennedy III, MD Rhabdomyolysis”. Приступљено 28. 4. 2010.